ES2181630T3 - Utilizacion terapeutica de una mezcla de helio/oxigeno, en particular en el tratamiento del asma. - Google Patents

Utilizacion terapeutica de una mezcla de helio/oxigeno, en particular en el tratamiento del asma.

Info

Publication number
ES2181630T3
ES2181630T3 ES00401750T ES00401750T ES2181630T3 ES 2181630 T3 ES2181630 T3 ES 2181630T3 ES 00401750 T ES00401750 T ES 00401750T ES 00401750 T ES00401750 T ES 00401750T ES 2181630 T3 ES2181630 T3 ES 2181630T3
Authority
ES
Spain
Prior art keywords
mixture
administration
bars
helio
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00401750T
Other languages
English (en)
Inventor
Laurent Lecourt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Air Liquide Sante International SA
Original Assignee
Air Liquide Sante International SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9547649&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2181630(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Air Liquide Sante International SA filed Critical Air Liquide Sante International SA
Application granted granted Critical
Publication of ES2181630T3 publication Critical patent/ES2181630T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics

Abstract

Mezcla gaseosa lista para su empleo constituida por el 63,1 al 69,9 % en volumen de helio y siendo el resto oxígeno, estando acondicionada dicha mezcla gaseosa a una presión superior a 2 bares.
ES00401750T 1999-07-02 2000-06-20 Utilizacion terapeutica de una mezcla de helio/oxigeno, en particular en el tratamiento del asma. Expired - Lifetime ES2181630T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908563A FR2795644B1 (fr) 1999-07-02 1999-07-02 Utilisations therapeutiques d'un melange helium/oxygene, en particulier dans le traitement de l'asthme

Publications (1)

Publication Number Publication Date
ES2181630T3 true ES2181630T3 (es) 2003-03-01

Family

ID=9547649

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00401750T Expired - Lifetime ES2181630T3 (es) 1999-07-02 2000-06-20 Utilizacion terapeutica de una mezcla de helio/oxigeno, en particular en el tratamiento del asma.

Country Status (11)

Country Link
US (1) US6592848B1 (es)
EP (1) EP1064945B1 (es)
JP (1) JP2001055337A (es)
AT (1) ATE222110T1 (es)
AU (1) AU771976B2 (es)
CA (1) CA2314173C (es)
DE (1) DE60000325T2 (es)
ES (1) ES2181630T3 (es)
FR (1) FR2795644B1 (es)
PT (1) PT1064945E (es)
ZA (1) ZA200003148B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164614B1 (es) * 2000-09-06 2003-05-16 Soc Es Carburos Metalicos Sa Mezcla de helio y oxigeno con aplicacion terapeutica.
US20030199594A1 (en) * 2002-04-23 2003-10-23 Rasik Shah Helium propellant composition for use with aerosols
GB0300586D0 (en) * 2003-01-10 2003-02-12 Btg Int Ltd Therapeutic microfoam
US7263993B2 (en) * 2003-01-21 2007-09-04 Vanderipe Donald R Method of use of gas mixtures to achieve washout of nitrogen from the body and mitochondria
GB0302196D0 (en) * 2003-01-30 2003-03-05 Boc Group Plc Medical apparatus
FR2932092A1 (fr) * 2008-06-05 2009-12-11 Air Liquide Melange gazeux he/o2 pour une utilisation lors d'une endoscopie avec insufflation de co2
US8393323B2 (en) 2008-09-30 2013-03-12 Covidien Lp Supplemental gas safety system for a breathing assistance system
DE102008054205A1 (de) * 2008-10-31 2010-05-06 Bayer Schering Pharma Aktiengesellschaft Verwendung von Helium-Sauerstoff-Gasgemischen zur Behandlung der pulmonalen arteriellen Hypertonie
US20120315614A1 (en) * 2011-06-07 2012-12-13 Krauza Matthew L Method for enhancing training effectiveness

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI47643C (fi) * 1969-02-25 1974-02-11 Interspiro Ab Menetelmä hapen syöttämiseksi sukeltajalle.
US3815591A (en) * 1972-04-28 1974-06-11 Union Carbide Corp Diving gas mixtures and methods of deep diving
FR2596989B1 (fr) * 1986-04-14 1990-05-18 Air Liquide Produit de radiosensibilisation des tissus biologiques en radiotherapie
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5570683A (en) * 1990-12-05 1996-11-05 The General Hospital Corporation Methods and devices for treating pulmonary vasoconstriction and asthma
DE69133575T2 (de) * 1990-12-05 2008-04-17 The General Hospital Corp., Boston Verwendung von NO zur Behandlung der persistenten pulmonaren Hypertonie des Neugeborenen
US5228434A (en) * 1991-07-16 1993-07-20 Praxair Technology, Inc. Mixture for anesthesia
DE4327731C1 (de) * 1993-08-18 1994-11-10 Messer Griesheim Gmbh NO-haltiges Gasgemisch zur Behandlung pulmonaler Erkrankungen
US5429123A (en) * 1993-12-15 1995-07-04 Temple University - Of The Commonwealth System Of Higher Education Process control and apparatus for ventilation procedures with helium and oxygen mixtures
SE502268C2 (sv) * 1994-01-26 1995-09-25 Aga Ab Sätt, användning och beredning av aerosol för läkemedelsdistribution innehållande helium och/eller neon
US6001332A (en) 1995-02-16 1999-12-14 The Boc Group Plc Medical gas mixture
GB9502987D0 (en) * 1995-02-16 1995-04-05 Boc Group Plc Medical gas mixture
GB9706817D0 (en) * 1997-04-04 1997-05-21 Boc Group Plc Medical gas mixtures
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same

Also Published As

Publication number Publication date
FR2795644B1 (fr) 2004-07-30
AU771976B2 (en) 2004-04-08
CA2314173C (fr) 2009-03-03
JP2001055337A (ja) 2001-02-27
AU4378100A (en) 2001-01-04
PT1064945E (pt) 2002-11-29
DE60000325D1 (de) 2002-09-19
US6592848B1 (en) 2003-07-15
DE60000325T2 (de) 2003-03-13
ATE222110T1 (de) 2002-08-15
FR2795644A1 (fr) 2001-01-05
CA2314173A1 (fr) 2001-01-02
EP1064945B1 (fr) 2002-08-14
EP1064945A1 (fr) 2001-01-03
ZA200003148B (en) 2001-03-05

Similar Documents

Publication Publication Date Title
ATE342053T1 (de) Formulierungen zur inhalation
BR0001599A (pt) Equipamento médico portátil para a produção de oxigênio utilizável em oxigenoterapia
MY129512A (en) Novel medicament compositions, based on tiotropium bromide and salmeterol
DE60231731D1 (de) Vorrichtung zur nasalen oder oralen verabreichung eines medikamentes
ATE294004T1 (de) Gerät zum bereitstellen einer atemgasmischung
UA27777C2 (uk) Пристрій для дозованої видачі відміряної кількості рідини у вигляді крапельного розпилу під тиском
KR920017643A (ko) 약제학적 에어로졸 제제
ES2181630T3 (es) Utilizacion terapeutica de una mezcla de helio/oxigeno, en particular en el tratamiento del asma.
AR009370A1 (es) UNA COMPOSICION FARMACEUTICA EN AEROSOL ADECUADA PARA LA ADMINISTRACION DE BUDESONIDA, UN PRODUCTO FARMACEUTICO QUE LA CONTIENE, UN METODO PARAADMINISTRAR BUDESONIDA Y USO DE UNA MEZCLA DE HFA 134a Y HFA 227
CA2447510A1 (en) Fluorocarbon aerosol medicaments
ATE418994T1 (de) Argon enthaltendes arzneimittel zum inhalieren und dessen verwendung zur behandlung von neurotoxizität
BG107257A (en) Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
PE20020793A1 (es) Agente preventivo y/o terapeutico de enfermedades inflamatorias del tracto respiratorio
DK0533896T3 (es)
FI962967A (fi) Menetelmä aerosolin valmistamiseksi
EP1110547A3 (en) Helium and neon as means delivering drug in inhaler
EP0868921A3 (en) Medical gas mixtures
CN201104982Y (zh) 高压氧舱内用供氧装置
BRPI0405298A (pt) Formulações lìquidas com base em paracetamol estáveis e um método para a preparação das mesmas
Redden et al. Anaesthesia and the accident flying squad: A new anaesthetic machine
AU2003215588A1 (en) Aerosol formulations containing esters of 3,17-dihydroxy oestratriene derivatives for pulmonary delivery